Kronox Lab Sciences Limited

BSE: 544187 NSE: KRONOX
Kronox Lab Sciences Limited - chemicals in Padra, Gujarat, India. FY 2026 financials & compliance.
CIN L24117GJ2008PLC055460 Incorporated 18 November 2008 ROC Ahmedabad HQ Padra, Gujarat, India
Active Listed - NSE: KRONOX · BSE: 544187 Public Limited Company chemicals MSME · Medium
Data last updated
Market Cap
₹718 Cr
KRONOX · NSE
Share Price
₹190.24
-1.69% today
Revenue
₹101 Cr
FY 2025-26 · +1.0% YoY
EBITDA
₹34.27 Cr
Margin 33.9%
Net Profit
₹27.60 Cr
FY 2025-26 · +8.4% YoY
P/E (TTM)
24.8x
P/B 5.5x
ROE
26.8%
ROCE 36.0%
Debt / Equity
0.01
Interest cover 0.3x

About Kronox Lab Sciences Limited

Data last updated:

Kronox Lab Sciences Limited is a public limited company based in Padra, Gujarat, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 18 November 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24117GJ2008PLC055460. Its GSTIN is 24AADCK5355N1Z8 (Gujarat). It is a listed company as per MCA records. Its shares are listed on BSE: 544187 and NSE: KRONOX.

The company has an authorised share capital of ₹54 Cr and a paid-up capital of ₹37.1 Cr. It was formerly known as Kronox Lab Sciences Private Limited. It is led by directors including Suresh Kalra (Managing Director) and Anuradha Suneet Maheshwari.

Its last annual general meeting (AGM) was held on 16 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Block No. 353 Village Ekalbara, Padra, Gujarat, India – 391440.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹101.22 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹27.6 Cr (net margin 27.3%) and EBITDA of ₹34.27 Cr (EBITDA margin 33.9%). The net worth stands at ₹116.12 Cr (up 28.9% YoY). Total assets are valued at ₹117.76 Cr (up 30.7% YoY).

The company has about 78 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: KRONOX Lab Sciences. As per MCA filings, the company has satisfied charges of ₹8.02 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 13 deals on record (8 market trades, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹24 Lakh; the latest was in August 2026. The company has 2 MSME Form 1 returns on record between 2020 and 2021, listing 14 overdue payments to 14 micro and small suppliers.

Kronox Lab Sciences Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0016186). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kronoxlabsciences.com.

Company details

CIN L24117GJ2008PLC055460
Registration Number 055460
Incorporation Date 18 November 2008
ROC Ahmedabad
Listing Status Listed - Listed on NSE (KRONOX); Listed on BSE (544187)
Company Status Active
Date of Last AGM 16 September 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-24-0016186

CIN history

Kronox Lab Sciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24117GJ2008PLC055460, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24117GJ2008PLC055460Current
U24117GJ2008PLC055460Previous
U24117GJ2008PTC055460Previous
Key People
Suresh Kalra Managing Director Anuradha Suneet Maheshwari Additional Director Dhananjay Vishnu Tapasvi Additional Director

Recognitions & Rankings of Kronox Lab Sciences

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-24-0016186

Contact details

Kronox Lab Sciences Limited's registered office is in Padra, Gujarat. Its website is kronoxlabsciences.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    kronoxlabsciences.com
  • Social Media
  • Registered Address
    Block No. 353 Village Ekalbara, Padra, Gujarat, India – 391440
  • Industry
    Chemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals

To see the full contact details of Kronox Lab Sciences Limited, buy the company report.

Comprehensive company report
Kronox Lab Sciences Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Kronox Lab Sciences operates one associated brand: KRONOX Lab Sciences. Each brand links to its own profile.

BrandDescriptionWebsite
KRONOX Lab Sciences
Manufacturer of high purity fine chemicals, specializing in chemical synthesis and analysiskronoxlabsciences.com

Business activity

The main business activity of Kronox Lab Sciences is manufacturing. In detail, this covers manufacture of chemicals and chemical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing20Manufacture of chemicals and chemical products

To see the full business activity and turnover split of Kronox Lab Sciences Limited, buy the company report.

Financials of Kronox Lab Sciences Limited

FY 2025-26 filings available

Kronox Lab Sciences Limited reported revenue of ₹101.22 Cr (up 1% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹101 Cr
+1.0% YoY
EBITDA
₹34.27 Cr
+3.5% YoY
Profit After Tax
₹27.60 Cr
+8.4% YoY
Net Worth
₹116 Cr
+28.9% YoY
Total Assets
₹118 Cr
+30.7% YoY
Total Debt
₹1.61 Cr

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue10110089.8695.5882.2562.4650.50
Revenue growth+1.0%+11.5%-6.0%+16.2%+31.7%+23.7%-
EBITDA34.2733.1228.3321.7119.6914.8011.71
EBITDA margin+33.9%+33.1%+31.5%+22.7%+23.9%+23.7%+23.2%
Profit before tax37.3034.2728.6222.0418.3413.2211.74
Net profit27.6025.4721.3616.3913.599.718.60
Net profit margin+27.3%+25.4%+23.8%+17.2%+16.5%+15.6%+17.0%
EPS (₹)7.456.865.754.42565.44403.73343.75
Balance sheet
Total assets11890.1366.3245.2444.2330.6123.40
Net worth11690.1066.3044.7540.3526.8123.34
Total debt1.610.000.000.003.363.620.03
Cash & bank48.7436.683.643.562.812.052.48
Net working capital69.0954.6038.9325.3831.6019.1716.27
Cash flow
Cash from operations23.8930.7017.4219.679.0211.314.48
Cash from investing(23.82)(28.39)(17.31)(6.60)(7.60)(2.96)(3.92)
Cash from financing(0.36)(1.85)0.00(13.40)(0.67)(7.10)(0.21)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue26.8328.3926.1325.2725.5324.2926.1324.01
Revenue growth (YoY)+5.1%+16.9%0.0%+5.3%+2.7%-3.6%--
Other income0.871.302.151.131.040.870.910.82
Total expenses18.4019.3916.6117.2516.8916.3218.3815.65
EBITDA8.439.009.528.028.647.977.758.36
EBITDA margin+31.4%+31.7%+36.4%+31.7%+33.8%+32.8%+29.7%+34.8%
Depreciation0.490.450.660.520.470.400.350.36
Interest0.080.030.040.040.040.000.000.00
Profit before tax8.739.8210.978.599.178.448.318.82
Tax2.292.512.962.012.502.172.002.30

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 11 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue26.8328.3926.1325.2725.5324.2926.1324.01
Revenue growth (YoY)+5.1%+16.9%0.0%+5.3%+2.7%-3.6%--
Other income0.871.302.151.131.040.870.910.82
Total expenses18.4019.3916.6117.2516.8916.3218.3815.65
EBITDA8.439.009.528.028.647.977.758.36
EBITDA margin+31.4%+31.7%+36.4%+31.7%+33.8%+32.8%+29.7%+34.8%
Depreciation0.490.450.660.520.470.400.350.36
Interest0.080.030.040.040.040.000.000.00
Profit before tax8.739.8210.978.599.178.448.318.82
Tax2.292.512.962.012.502.172.002.30
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue10110089.8695.5882.2562.4650.50
Revenue growth+1.0%+11.5%-6.0%+16.2%+31.7%+23.7%-
Other income5.192.531.581.921.090.781.07
Total expenses66.9567.0761.5373.8762.5647.6638.79
Employee cost3.442.952.501.931.651.491.20
EBITDA34.2733.1228.3321.7119.6914.8011.71
EBITDA margin+33.9%+33.1%+31.5%+22.7%+23.9%+23.7%+23.2%
Depreciation2.051.381.291.502.031.980.96
Interest0.110.000.000.090.410.380.08
Profit before tax37.3034.2728.6222.0418.3413.2211.74
Tax9.648.807.265.644.733.493.14
Net profit27.6025.4721.3616.3913.599.718.60
Net profit margin+27.3%+25.4%+23.8%+17.2%+16.5%+15.6%+17.0%
EPS (₹)7.456.865.754.42565.44403.73343.75
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital37.1037.1037.1037.100.240.240.25
Reserves & surplus79.0253.0029.207.6540.1126.5723.09
Shareholders' funds (net worth)11690.1066.3044.7540.3526.8123.34
Secured loans1.610.000.000.000.170.010.03
Unsecured loans0.000.000.000.003.193.610.00
Total debt1.610.000.000.003.363.620.03
Total liabilities11890.1366.3245.2444.2330.6123.40
Assets
Gross block42.8840.3137.4825.6921.7417.7112.19
Net block28.7327.8626.4115.9111.309.195.54
Capital work in progress0.880.760.490.000.000.400.00
Investments0.030.030.030.030.030.030.03
Inventories8.376.379.259.177.515.495.04
Sundry debtors21.1919.8917.6518.5525.8015.4415.19
Cash & bank balances48.7436.683.643.562.812.052.48
Loans & advances0.550.3616.062.908.043.234.39
Total current assets78.8563.3046.6034.1844.1626.2127.10
Total current liabilities9.768.707.678.8012.567.0410.83
Net working capital69.0954.6038.9325.3831.6019.1716.27
Total assets11890.1366.3245.2444.2330.6123.40
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash3.042.592.482.812.050.790.44
Net cash from operating activities23.8930.7017.4219.679.0211.314.48
Net cash from investing activities(23.82)(28.39)(17.31)(6.60)(7.60)(2.96)(3.92)
Net cash from financing activities(0.36)(1.85)0.00(13.40)(0.67)(7.10)(0.21)
Net change in cash(0.29)0.450.10(0.33)0.761.260.35
Closing cash48.7436.683.643.562.812.052.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+1.0%+11.5%-6.0%+16.2%+31.7%+23.7%-
EBITDA growth+3.5%+16.9%+30.5%+10.3%+33.0%+26.4%-
PBT growth+8.8%+19.7%+29.9%+20.2%+38.7%+12.6%+9997.0%
Net income growth+8.4%+19.2%+30.3%+20.6%+40.0%+12.9%-
Revenue CAGR (3Y)+1.9%+6.8%+12.9%+23.7%---
EBITDA CAGR (3Y)+16.4%+18.9%+24.2%+22.9%---
Profitability & leverage
Net income margin+27.3%+25.4%+23.8%+17.2%+16.6%+15.6%+17.0%
Return on capital employed+36.0%+43.8%+51.3%+50.2%+50.2%+50.4%+50.5%
Return on net worth+26.8%+32.6%+38.5%+39.1%+40.6%+38.8%+36.8%
Debt / equity0.010.000.000.040.100.070.00
Long-term debt / equity0.000.000.000.030.070.050.00
Interest cover0.340.000.000.452.322.960.74
Efficiency & per share
Fixed asset turnover2.432.582.854.034.174.184.14
Inventory turnover13.7312.839.7611.4612.6511.8610.02
Debtors turnover4.935.344.964.313.994.083.32
EPS (₹)7.456.865.754.42565.44403.73343.75
Dividend per share (₹)0.500.500.500.000.000.000.00
Book value per share (₹)31.3024.2817.8712.061,674.401,112.61933.52

To see the full year-wise statements and ratios of Kronox Lab Sciences Limited, buy the company report.

Board of directors of Kronox Lab Sciences Limited

Kronox Lab Sciences has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anuradha Suneet MaheshwariAdditional Director29 Sep 20260 Years 1 MonthsCurrent
Dhananjay Vishnu TapasviAdditional Director29 Sep 20260 Years 1 MonthsCurrent
Amit Kumar SharmaAdditional Director29 Sep 20260 Years 1 MonthsCurrent
Sunil Malhotra
Also directs: She Capital LLP, Zenstone Tradex LLP, Candy Floss Hospitality LLP and 5 more
Additional Director29 Sep 20260 Years 1 MonthsCurrent
Harsh Malhotra
Also directs: Indo Borax & Chemicals Limited, Indoborax Infrastructure Private Limited, Fountaincap Managers LLP and 4 more
Additional Director29 Sep 20260 Years 1 MonthsCurrent
Suresh Kalra
Also directs: Indo Borax & Chemicals Limited
Managing Director29 Sep 20260 Years 1 MonthsCurrent
View all directors

Auditor

Kronox Lab Sciences Limited is audited by Mahesh Udhwani & Associates for the financial year 2025.

Auditor firmFinancial yearFirm registration number
Mahesh Udhwani & AssociatesFY 2025129738W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 74.20%, foreign institutional investors hold 0.00%, domestic institutional investors hold 2.10% and retail and other public shareholders hold 23.70%.

Promoters: 74.20%DII (Domestic Institutional): 2.10%Retail & Others: 23.70%
Sep 2026
QUARTER
74.20% Promoters
2.10% DII (Domestic Institutional)
23.70% Retail & Others
Promoter holding - history
Now 74.20% · Sep 2026High 74.20% · Dec 2025Low 74.20% · Dec 2025
73%73.8%74.5%75.3%76%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 74.20%Mar 2026: 74.20%Jun 2026: 74.20%Sep 2026: 74.20%74.20%74.20%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters74.20%74.20%74.20%74.20%
Public25.80%25.80%25.80%25.80%

Charges & borrowings

Open charges
None
Satisfied charges
₹8.02 Cr
Breakdown by lending institutions
Bank of India₹5.22 Cr
Hdfc Bank Limited₹2.80 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Jun 2025101112756Hdfc Bank Limited₹2.03 CrSatisfied
29 Jul 2021100477515Hdfc Bank Limited₹21.69 LakhSatisfied
06 Apr 2021100444678Hdfc Bank Limited₹56.07 LakhSatisfied
23 Dec 201010257589Bank of India₹45 LakhSatisfied
27 Jul 200910170841Bank of India₹4.77 CrSatisfied

To see the full charge records of Kronox Lab Sciences Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Kronox Lab Sciences Limited has 13 deals on record (8 market trades, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹24 Lakh; the latest was in August 2026.

Total deals
13
Market trades
8
Secondary share transfers
2
Funding round
1
IPO
1
Disclosed funding
₹24 Lakh

Deals on record (5 of 13)

WhenDealAmountParties
Aug 2026Market trade₹7.28 CrBuyer: Irage Broking Services LLP
Seller: Irage Broking Services LLP
Aug 2026Acquisition₹246.12 CrBuyer: Indo Borax & Chemicals Limited
Nov 2024Market trade₹4.14 CrBuyer: Aakraya Research LLP
Seller: Aakraya Research LLP
Sep 2024Market trade₹6.18 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP
Sep 2024Market trade₹9.03 CrBuyer: Graviton Research Capital LLP
Seller: Chanakya Opportunities Fund I, Graviton Research Capital LLP

To see the full deal history of Kronox Lab Sciences Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Kronox Lab Sciences Limited has 2 MSME Form 1 returns on record between 2020 and 2021, listing 14 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 14)

SupplierAmount dueDue sinceReported on
Sparchem
an individual supplier
Developmental & Eco-Friendly Enterprises
New India Acid (Baroda) Private Limited
Nitrochem India Private Limited (Transfer Company)

To see the full MSME payment records of Kronox Lab Sciences Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Kronox Lab Sciences Limited has a workforce of 78 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
78
Active EPFO establishments
1
Employee growth
18.2%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2778
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Kronox Lab Sciences Limited, buy the company report.

GST

Kronox Lab Sciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AADCK5355N1Z8GujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Kronox Lab Sciences Limited, buy the company report.

Recent activity

Kronox Lab Sciences Limited has 16 board changes on record since 2019: 11 appointments and 5 cessations. The latest: Amit Kumar Sharma was appointed as Additional Director on 29 Sep 2026.

Appointed
Amit Kumar Sharma was appointed as Additional Director.
Appointed
Anuradha Suneet Maheshwari was appointed as Additional Director.
Appointed
Dhananjay Vishnu Tapasvi was appointed as Additional Director.
Appointed
Harsh Malhotra was appointed as Additional Director.
Appointed
Sunil Malhotra was appointed as Additional Director.
Appointed
Suresh Kalra was appointed as Managing Director.
AGM
Kronox Lab Sciences Limited last Annual general meeting of members was held on 16 Sep 2026 as per latest MCA records.
Charges
A charge registered on 18 Jun 2025 via Charge ID 101112756 with Hdfc Bank Limited was fully satisfied on 12 Aug 2026.
Filing
Kronox Lab Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
Ceased
Satish Kumar ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.03 Cr with Charge ID 101112756 was registered on 18 Jun 2025.
Ceased
Aditya Vikrambhai Patel ceased to be Company Secretary.

18 earlier events are in the company report.

News

Kronox Lab Sciences: Gets Approval To Buy 5000 Square Meter Plant In Dahej SEZ From Axiom Chemicals; Plans To Increase Manufacturing Capacity; Deal Funded By Internal Earnings.
14 Oct 2026 · Exchange Update
Kronox Lab Sciences: Names Shashikant Bharuka as New CFO.
29 Sep 2026 · Exchange Update

Frequently asked questions

Kronox Lab Sciences is an active public limited company based in Padra, Gujarat, India. The company works in chemical products, within the chemicals industry. It was incorporated on 18 November 2008 (18+ years old) and is registered under CIN L24117GJ2008PLC055460. Listed on BSE: 544187 and NSE: KRONOX.

Kronox Lab Sciences reported revenue of ₹101.22 Cr for FY 2025-26 (up 1% YoY) based on standalone financials.

Kronox Lab Sciences has 6 current directors:

The latest financial statements of Kronox Lab Sciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 16 September 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of Kronox Lab Sciences is 24AADCK5355N1Z8, registered in Gujarat.

The CIN (Corporate Identification Number) of Kronox Lab Sciences is L24117GJ2008PLC055460. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Kronox Lab Sciences is a listed company as per MCA records. Its shares are listed on both BSE (code: 544187) and NSE (symbol: KRONOX).

Kronox Lab Sciences has 2 court cases on record: 2 filed by the company. Most are in the district courts.

Kronox Lab Sciences was incorporated on 18 November 2008, making it 18+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Kronox Lab Sciences has 13 deals on record (8 market trades, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹24 Lakh; the latest was in August 2026.

Amit Kumar Sharma was appointed as Additional Director on 29 Sep 2026. Anuradha Suneet Maheshwari was appointed as Additional Director on 29 Sep 2026. Dhananjay Vishnu Tapasvi was appointed as Additional Director on 29 Sep 2026. Kronox Lab Sciences has 16 board changes on record in total.